Literature DB >> 15163274

Management of pituitary apoplexy.

Philippe Chanson1, Jean-François Lepeintre, Denis Ducreux.   

Abstract

Pituitary apoplexy is a rare clinical syndrome caused by sudden haemorrhaging or infarction of the pituitary gland, generally within a pituitary adenoma. Headache of sudden and severe onset is the main symptom, associated with visual disturbances or ocular palsy. Signs of meningeal irritation or altered consciousness may complicate the diagnosis. Corticotropic deficiency (secondary adrenal failure) may be life-threatening if untreated. Computed tomography (CT) or magnetic resonance imaging (MRI) confirm the diagnosis by revealing a pituitary tumour with haemorrhagic and/or necrotic components: CT is most useful in the acute setting (24 - 48 h), MRI is useful for identifying blood components in the subacute setting (4 days to 1 month). Owing to the highly variable course of this syndrome and the limited individual experience, the optimal management of acute pituitary apoplexy is controversial. Some authors advocate early transphenoidal surgical decompression for all patients, whereas others adopt a more conservative approach for selected patients (those without visual acuity or field defects and with normal consciousness). Glucocorticoid treatment must always be initiated immediately, at a dose of hydrocortisone 50 mg every 6 h.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163274     DOI: 10.1517/14656566.5.6.1287

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  12 in total

1.  Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy.

Authors:  Ju-Wan Seuk; Choong-Hyun Kim; Moon-Sul Yang; Jin-Hwan Cheong; Jae-Min Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30

2.  Pituitary tumour apoplexy following acute coronary syndrome management.

Authors:  Sanjay K Kohli; Paresh Mehta; Richard Grocott-Mason; Simon William Dubrey
Journal:  BMJ Case Rep       Date:  2009-05-12

3.  Surgical treatment for severe visual compromised patients after pituitary apoplexy.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Kuo-Chen Wei; Cheng-Chih Liao; Peng-Wei Hsu; Ying-Cheng Huang; Yao-Liang Chen; Li-Ju Lai; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

4.  A conservative management is preferable in milder forms of pituitary tumor apoplexy.

Authors:  C Leyer; F Castinetti; I Morange; M Gueydan; C Oliver; B Conte-Devolx; H Dufour; T Brue
Journal:  J Endocrinol Invest       Date:  2010-08-31       Impact factor: 4.256

5.  An altered state of consciousness while using anticoagulants and the incidental discovery of a pituitary lesion: considering pituitary apoplexy.

Authors:  N Viola; C Urbani; M Cosottini; A Abruzzese; L Manetti; G Cosentino; G Marconcini; C Marcocci; F Bogazzi; I Lupi
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2022-06-01

6.  Effect of transsphenoidal surgery on decreased visual acuity caused by pituitary apoplexy.

Authors:  Naoya Takeda; Katsuzo Fujita; Shigenori Katayama; Nobuyuki Akutu; Shigeto Hayashi; Eiji Kohmura
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

7.  Pituitary apoplexy.

Authors:  Salam Ranabir; Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2011-09

Review 8.  Headache in pregnancy: an approach to emergency department evaluation and management.

Authors:  Jessica C Schoen; Ronna L Campbell; Annie T Sadosty
Journal:  West J Emerg Med       Date:  2015-02-25

9.  Pituitary apoplexy: an update on clinical and imaging features.

Authors:  Alessandro Boellis; Alberto di Napoli; Andrea Romano; Alessandro Bozzao
Journal:  Insights Imaging       Date:  2014-10-16

10.  Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.

Authors:  Fergus Keane; Aoife M Egan; Patrick Navin; Francesca Brett; Michael C Dennedy
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.